At week 12 , the mean change from the baseline in micturitions/24 hours ( primary endpoint ) was -2.4 for tolterodine ER versus -0.8 for placebo [ treatment difference ( 95 % CI ) : -1.6 ( -3.9 , 0.6 ) ] .